Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/79415
Type: Artigo de Periódico
Title: Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
Authors: Nuno Faria
John McCrone
Ruben Hulswit
Lucas Franco
Mariana Ramundo
Jaqueline de Jesus
Pamela. Andrade
Thais Coletti
Giulia Ferreira
Camila Silva
Erika Manuli
Thomas Mellan
Rafael Pereira
Pedro Peixoto
Moritz Kraemer
Nelson Gaburo
Cecilia da Camilo
Henrique Hoeltgebaum
William Souza
Esmenia Rocha
Leandro de Souza
Mariana de Pinho
Charles Whittaker
Leonardo Araujo
Frederico Malta
Aline de Lima
Joice do Silva
Danielle Zauli
Alessandro de Ferreira
Ricardo Schnekenberg
Daniel Laydon
Patrick Walker
Hannah Schlüter
Ingra Claro
Ana dos Santos
Maria Vidal
Valentina Del Caro
Rosinaldo Filho
Helem Dos Santos
Renato Santana de Aguiar
José Proença-Modena
Bruce Nelson
James Hay
Mélodie Monod
Darlan da Candido
Xenia Miscouridou
Helen Coupland
Raphael Sonabend
Michaela Vollmer
Axel Gandy
Carlos Prete
Vitor Nascimento
Marc Suchard
Thomas Bowden
Sergei Pond
Swapnil Mishra
Chieh-hsi Wu
Oliver Ratmann
Neil Ferguson
Christopher Dye
Nick Loman
Philippe Lemey
Andrew Rambaut
Nelson Fraiji
Maria do Carvalho
Oliver Pybus
Myuki Crispim
Seth Flaxman
Samir Bhatt
Ester Sabino
Flavia Sales
Iwona Hawryluk
Abstract: Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Manaus, Brazil,resurged in late 2020 despite previously high levels of infection. Genome sequencing of viruses sampledin Manaus between November 2020 and January 2021 revealed the emergence and circulation of anovel SARS-CoV-2 variant of concern. Lineage P.1 acquired 17 mutations, including a trio in thespike protein (K417T, E484K, and N501Y) associated with increased binding to the human ACE2(angiotensin-converting enzyme 2) receptor. Molecular clock analysis shows that P.1 emergenceoccurred around mid-November 2020 and was preceded by a period of faster molecular evolution. Usinga two-category dynamical model that integrates genomic and mortality data, we estimate that P.1may be 1.7- to 2.4-fold more transmissible and that previous (non-P.1) infection provides 54 to 79% ofthe protection against infection with P.1 that it provides against non-P.1 lineages. Enhanced globalgenomic surveillance of variants of concern, which may exhibit increased transmissibility and/or immuneevasion, is critical to accelerate pandemic responsiveness.
Subject: COVID-19 (Doença)
SARS-CoV-2
Pandemia
Microbiologia
language: eng
metadata.dc.publisher.country: Brasil
Publisher: Universidade Federal de Minas Gerais
Publisher Initials: UFMG
metadata.dc.publisher.department: ICB - INSTITUTO DE CIÊNCIAS BIOLOGICAS
Rights: Acesso Aberto
metadata.dc.identifier.doi: https:// doi:10.1126/science.abh2644
URI: http://hdl.handle.net/1843/79415
Issue Date: 14-Apr-2021
metadata.dc.url.externa: https://www.science.org/doi/full/10.1126/science.abh2644?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org
metadata.dc.relation.ispartof: Science
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
Genomics and epidemiology of the P.1 SARS-CoV-2lineage in Manaus, Brazil.pdf8.78 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.